Albert Power

Dr Albert Power is a consultant nephrologist and lead for clinical research at the Richard Bright Renal Unit based in Southmead Hospital in Bristol, UK. He has a specialist interest in blood purification therapies with a particular focus on hemodialysis. He graduated from Gonville & Caius College, University of Cambridge and subsequently undertook an MD in Nephrology at Imperial College London. As the NIHR Academic Clinical Lecturer in Renal Medicine in the Renal Section of the Division of Immunity & Inflammation in the Department of Medicine, he has been a principal member of the Dialysis Research Group at the Imperial Renal & Transplant Centre. His research interests include coagulation in end-stage renal disease, vascular access function and the pathogenesis of cerebrovascular disease. Current research is focused on stroke pathophysiology & outcomes in patients with renal disease through regional, national and international research initiatives as well as elucidating the determinants of cognitive dysfunction in patients on dialysis therapies. Dr Power remains a principal investigator within the international MONDO (Monitoring Dialysis Outcomes) research initative, and has ongoing work with UK Renal Registry in the field of cerebrovascular disease. He is Lead for Renal Disorders for the UK National Institute of Health Research CRN: West of England.